For certain side effects of complex and lifesaving medical procedures, care teams can be left with limited and risky treatment options, but a program at UW Health is changing that using patients’ own cells as “living …
Uncategorized
PACT Director named one of Medicine Maker’s 2022 top 10 influential people in advanced medicine.
Don and Marilyn Anderson Professor of Oncology and Associate Dean for Therapeutics Development, University of Wisconsin in Madison, US Galipeau is the president-elect of the International Society for Cell Therapy and the director of the …
PACT well represented at ISCT Annual Meeting
Several members of PACT’s staff recently attended the 2022 Annual Meeting of the International Society for Cell & Gene Therapy, May 4-7, 2022, in San Francisco, CA. From bench research to cell manufacturing, many aspects …
PACT Director inducted as ISCT President
PACT Director Jacques Galipeau, MD, FRCP, was officially inducted as President of the International Society of Cell and Gene Therapy at their annual meeting in San Francisco, May 4-7, 2022. Galipeau officially replaces Bruce Levine, …
Andrea Pennati, Ph.D. promoted to Director of R&D
The Program for Advanced Cellular Therapy is excited to announce the promotion of Andrea Pennati, Ph.D., to Director of Research and Development. In this role, Dr. Pennati is responsible for the transition of UW’s pre-clinical …
Galipeau speaks at Neurosurgery Grand Rounds
Jacques Galipeau, MD, FRCP, PACT Director, recently presented at the Department of Neurosurgery Grand Rounds. The full presentation, “Mesenchymal Stromal Cells for TBI – A first-in-human clinical trial proposal,” can be viewed below:
KIM MCDOWELL PROMOTED TO DIRECTOR OF REGULATORY AFFAIRS FOR PROGRAM FOR ADVANCED CELL THERAPY
Kimberly McDowell, MD, PhD, has been named Director of Regulatory Affairs for the UW Program for Advanced Cell Therapy (PACT). McDowell has served as the program’s associate director of regulatory affairs since 2019, and has …
Galipeau Chats with UWCCC Emerging Leadership Board
In December 2020, PACT Director Jacques Galipeau took part in Emerging Leadership Board at UW Carbone Cancer Center’s Five Minutes at Five Q&A session about his work in the PACT Program. To view the interview, …
UW Carbone Cancer Center Receives FDA Clearance to Test New Regenerative Medicine Therapy for Radiotherapy-Induced Dry Mouth
The University of Wisconsin Carbone Cancer Center has the go-ahead to start clinical trials on a first-in-human cell therapy to treat a common side effect of radiation therapy. This investigational new drug license, or IND, recently …
UW Program launches first-in-US cell-therapy trial for kidney transplant patients
MADISON, Wis. – For the first time in the United States, a research team will test a personalized cell therapy to treat a common and serious complication facing kidney transplant patients. The UW Program for …